Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05399576

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University (from the registry)
Registry
  • NCT NCT05399576
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05399576. Randomized; double masking; primary purpose prevention. Start 2022-05-17 (actual); primary completion 2023-05-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury
Intervention (Drug)
Nicorandil
Intervention (Drug)
Saline
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University (class: other)

Record details

Record id
cardio:ct-nct05399576
Content hash
ae00b12f73faabe955e3df9cd8a6572fbdffcd6a84f1f62a325c82e62b974900